Search results for "vaccines"
Article
Analytical Considerations for Successful Upstream Process Development with Spivey and Lane
Cytiva provides bioprocessing products and services to the biopharmaceutical industry for the development and manufacturer of therapeutics and vaccines. The company uses its scientific knowledge and t…
Article
Cell-free Expression Systems Pose Cell Culture Alternative
…luding demonstrating portable, inexpensive, and rapid biomanufacturing of protective glycoconjugate vaccines without a cold chain (11).”
With GMP manufacturing already established with the wo…
Article
Accelerating an Orphan Therapy to Market
Click here to learn more >>
This case study shares the work of Cytiva’s Fast Trak Services team to help accelerate development of a process for cGMP production of material for toxicology studies.…
Article
EMA Confirms Standards for COVID-19 Treatment Evaluations
30, 2020, detailing the agency’s transparency plans for COVID-19 treatments and affirming its commitment to independence in the evaluation of COVID-19 treatments and vaccines. The letter was in respon…
Article
Preparing for the Future Visions and Insights for Biomanufacturing
Click here to learn more >>
The biopharmaceutical industry has a reputation of being averse to change. Yet, new market dynamics, such as growing competition from biosimilars and niche drugs targe…
Article
Epitope Binning: A Critical Step in Antibody Selection
Read about how surface plasmon resonance (SPR) is used to characterize closely related “bins” of monoclonal antibodies (mAbs) targeting the same epitope of the target protein, and how the selection …
Article
Mapping a Route for Cell and Gene Therapy Process Development
While cell and gene therapies differ in many ways, some of the best practices for process development and validation are similar.
By Cynthia A. Challener
…
Article
Scalable ADCF Virus Production Using HyClone™ VaccineXpress Medium
In this study, HyClone VaccineXpress cell culture medium was used for the propagation of influenza virus and rotavirus in an animal-derived component-free (ADCF) process. Small-scale microcarrier cu…
Article
2019’s Top Bioprocessing Trends and What to Expect in 2020
In 2019, a novel production process for adenovirus vectors—used in cancer gene therapy trials and evaluated for use in vaccines—got attention for its technical and process economic advantages compared…
Article
The Evolving Role of Starting Materials in Cell and Gene Therapy
Unlike other biological drug products such as therapeutic proteins, monoclonal antibodies, or vaccines, drugs based on living cells are by nature uniquely vulnerable to supply chain complications and …